About CogRx
Cognition Therapeutics, Inc. is a clinical-stage neuroscience company developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders.
Founded in 2007 by Gilbert M. Rishton and Susan Catalano.
- Founded
- 2007
- Employees
- 11 to 50
- Total funding
- $177.1M
- Headquarters
- Harrison
Leadership
The top of CogRx's org chart, with how many people report into each leader.
Lisa Ricciardi
President/ Chief Executive Officer & Board Member
17 reports
Anthony Caggiano
Chief Medical Officer and Head of R&D
6 reports
Anthony O. Caggiano
Chief Medical Officer And Head Of R&d
4 reports
John Doyle
Chief Financial Officer
3 reports
Gilbert M. Rishton
Co-Founder and Chief Chemist
Board
Steven DeKosky
Medical Advisor
Rolf Craven
Scientific Advisor
John Harrison
Medical Advisor
John Cirrito
Scientific Advisor
Tara L. Spires-Jones
Scientific Advisor
Robert H. Mach
Scientific Advisor
Jobs at CogRx
No open positions right now. Explore more companies on TheJobsMap.